uric acid has been researched along with Fetal Growth Restriction in 48 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Because of the significant discrepancies on this topic, this review will focus on the role of uric acid in PE, uric acid as a predictor of preeclampsia and fetal growth retardation." | 8.98 | The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia? ( Khaliq, OP; Konoshita, T; Moodley, J; Naicker, T, 2018) |
| "To determine the accuracy with which serum uric acid predicts maternal and fetal complications in women with pre-eclampsia." | 8.83 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. ( Coomarasamy, A; Ismail, KM; Khan, KS; Sharp, S; Thangaratinam, S, 2006) |
| "Previous evidence suggests that higher blood uric acid (UA) levels are associated with adverse cardiovascular outcomes during pregnancy and subsequent birth outcomes." | 8.31 | Associations of early pregnancy serum uric acid levels with risk of gestational diabetes and birth outcomes: a retrospective cohort study. ( Chen, GD; Guo, XL; Li, PS; Liu, ZP; Ma, HT; Pang, TT; Shen, XY; Wan, YC; Zhou, ZX, 2023) |
| " In this study, we attempted to assess whether uric acid could be used as a secondary marker in estimating the pregnancy risk associated with LBW." | 8.12 | Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study. ( Bednarek-Jędrzejek, M; Cymbaluk-Płoska, A; Czuba, B; Dzidek, S; Góra, T; Kwiatkowska, E; Kwiatkowski, S; Torbé, A; Tousty, P, 2022) |
| "Maternal serum uric acid concentration is a good predictor of fetal/neonatal outcomes in women with pre-eclampsia/eclampsia." | 7.91 | Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. ( Cao, TN; Le, DD; Le, TM; Nguyen, HVQ; Nguyen, LH; Phan, NL; Truong, VQ, 2019) |
| " In our previous study, we showed that serum strontium (Sr) levels were elevated in preeclamptic women compared to healthy and GH pregnant women at the end of pregnancy." | 7.91 | Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia. ( Álvarez, FV; Barneo-Caragol, C; Lequerica-Fernández, P; Martínez-Morillo, E; Rodríguez-González, S; Vega-Naredo, I, 2019) |
| "The relationship between hyperuricemia and hypertensive disorders is well established; however, until today, the role of uric acid in the clinical course of severe preeclampsia has not been elucidated." | 7.88 | Uric Acid in Pregnancy: New Concepts. ( Briones Garduño, JC; Diaz de Leon Ponce, MA; Moreno Santillan, AA, 2018) |
| " Lupus flares were predicted by HCQ discontinuation, a history of lupus nephritis, high pre-pregnancy serum uric acid and low C4 levels." | 7.81 | Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. ( Ju, JH; Ko, HS; Koh, JH; Kwok, SK; Park, SH, 2015) |
| "We sought to investigate whether uric acid concentrations are increased in pregnant women with insulin resistance and to correlate both with fetal growth." | 7.75 | Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. ( Catov, J; Laughon, SK; Roberts, JM, 2009) |
| " Isocaloric and isonitrogenous supplementation with glycine did not influence hypoxia-induced fetal growth restriction." | 7.70 | Dietary L-arginine prevents fetal growth restriction in rats. ( Harvey-Wilkes, KB; Hassoun, PM; Vosatka, RJ, 1998) |
| "There is no evidence from this study to support the association between perinatal deaths and higher uric acid levels in patients with severe pre-eclampsia." | 7.69 | Are high uric acid levels in patients with early pre-eclampsia an indication for delivery? ( Odendaal, HJ; Pienaar, ME, 1997) |
| "Factor VIII related antigen (VIIIRAg), Factor VIII coagulant activity (VIIIC), plasma uric acid, total plasma oestriol, plasma human placental lactogen (hPL) and urine oestrogen/creatinine ratio were measured in a group of 21 patients clinically suspected of fetal growth retardation and compared with normal pregnancy." | 7.66 | Factor VIII related antigen/coagulant activity ratio as a predictor of fetal growth retardation: a comparison with hormone and uric acid measurements. ( Howie, PW; Prentice, CR; Shah, MM; Whigham, KA, 1980) |
| "The precise etiopathogenesis of preeclampsia (PE) still remains enigmatic." | 5.43 | Second trimester amniotic fluid uric acid, potassium, and cysteine to methionine ratio levels as possible signs of early preeclampsia: A case report. ( Athanasiadis, AP; Biliaderis, CG; Fotiou, M; Koulourida, V; Masoura, S; Menexes, G; Michaelidou, AM; Tarlatzis, BC, 2016) |
| "Medical records of patients with preeclampsia and patients with PIH who delivered at term between January 2003 and December 2004 were reviewed." | 5.35 | Retinopathy in preeclampsia: association with birth weight and uric acid level. ( Gupta, A; Kaliaperumal, S; Rao, VA; Setia, S; Suchi, ST, 2008) |
| "Because of the significant discrepancies on this topic, this review will focus on the role of uric acid in PE, uric acid as a predictor of preeclampsia and fetal growth retardation." | 4.98 | The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia? ( Khaliq, OP; Konoshita, T; Moodley, J; Naicker, T, 2018) |
| "To determine the accuracy with which serum uric acid predicts maternal and fetal complications in women with pre-eclampsia." | 4.83 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. ( Coomarasamy, A; Ismail, KM; Khan, KS; Sharp, S; Thangaratinam, S, 2006) |
| "Previous evidence suggests that higher blood uric acid (UA) levels are associated with adverse cardiovascular outcomes during pregnancy and subsequent birth outcomes." | 4.31 | Associations of early pregnancy serum uric acid levels with risk of gestational diabetes and birth outcomes: a retrospective cohort study. ( Chen, GD; Guo, XL; Li, PS; Liu, ZP; Ma, HT; Pang, TT; Shen, XY; Wan, YC; Zhou, ZX, 2023) |
| " In this study, we attempted to assess whether uric acid could be used as a secondary marker in estimating the pregnancy risk associated with LBW." | 4.12 | Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study. ( Bednarek-Jędrzejek, M; Cymbaluk-Płoska, A; Czuba, B; Dzidek, S; Góra, T; Kwiatkowska, E; Kwiatkowski, S; Torbé, A; Tousty, P, 2022) |
| " In our previous study, we showed that serum strontium (Sr) levels were elevated in preeclamptic women compared to healthy and GH pregnant women at the end of pregnancy." | 3.91 | Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia. ( Álvarez, FV; Barneo-Caragol, C; Lequerica-Fernández, P; Martínez-Morillo, E; Rodríguez-González, S; Vega-Naredo, I, 2019) |
| "Maternal serum uric acid concentration is a good predictor of fetal/neonatal outcomes in women with pre-eclampsia/eclampsia." | 3.91 | Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. ( Cao, TN; Le, DD; Le, TM; Nguyen, HVQ; Nguyen, LH; Phan, NL; Truong, VQ, 2019) |
| "The relationship between hyperuricemia and hypertensive disorders is well established; however, until today, the role of uric acid in the clinical course of severe preeclampsia has not been elucidated." | 3.88 | Uric Acid in Pregnancy: New Concepts. ( Briones Garduño, JC; Diaz de Leon Ponce, MA; Moreno Santillan, AA, 2018) |
| " Lupus flares were predicted by HCQ discontinuation, a history of lupus nephritis, high pre-pregnancy serum uric acid and low C4 levels." | 3.81 | Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. ( Ju, JH; Ko, HS; Koh, JH; Kwok, SK; Park, SH, 2015) |
| "Gestational age at first presentation < 32 weeks, gestation-standardised blood pressure parameters and serum uric acid were more predictive of the development of preeclampsia, delivery before 34 weeks, severe hypertension and fetal growth restriction than absolute values." | 3.76 | Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension. ( Anumba, DO; Lincoln, K; Robson, SC, 2010) |
| "We sought to investigate whether uric acid concentrations are increased in pregnant women with insulin resistance and to correlate both with fetal growth." | 3.75 | Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. ( Catov, J; Laughon, SK; Roberts, JM, 2009) |
| " Their serum uric acid levels were correlated with the development of HELLP syndrome, severity of hypertension, and incidence of SGA newborns (< 10th percentile birth weight)." | 3.71 | The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies. ( Galerneau, F; Williams, KP, 2002) |
| " Isocaloric and isonitrogenous supplementation with glycine did not influence hypoxia-induced fetal growth restriction." | 3.70 | Dietary L-arginine prevents fetal growth restriction in rats. ( Harvey-Wilkes, KB; Hassoun, PM; Vosatka, RJ, 1998) |
| "To evaluate the variations and potential clinical use of serial maternal alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) in pregnancies at risk of pregnancy-induced hypertension (PIH) and/or intrauterine growth retardation (IUGR), we investigated the relationship between placental sonographic findings, uterine artery Doppler measurements, and maternal serum AFP, hCG, and uric acid levels between 20 and 34 weeks of pregnancy." | 3.69 | Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. ( Campbell, S; Gulbis, B; Jauniaux, E; Meuris, S; Ramsay, B; Tunkel, S, 1996) |
| "There is no evidence from this study to support the association between perinatal deaths and higher uric acid levels in patients with severe pre-eclampsia." | 3.69 | Are high uric acid levels in patients with early pre-eclampsia an indication for delivery? ( Odendaal, HJ; Pienaar, ME, 1997) |
| "Factor VIII related antigen (VIIIRAg), Factor VIII coagulant activity (VIIIC), plasma uric acid, total plasma oestriol, plasma human placental lactogen (hPL) and urine oestrogen/creatinine ratio were measured in a group of 21 patients clinically suspected of fetal growth retardation and compared with normal pregnancy." | 3.66 | Factor VIII related antigen/coagulant activity ratio as a predictor of fetal growth retardation: a comparison with hormone and uric acid measurements. ( Howie, PW; Prentice, CR; Shah, MM; Whigham, KA, 1980) |
| "The pregnancy was normal in 54% of patients in group A and 23% in group B (p less than 0." | 2.65 | [Controlled trial of preventive treatment of preeclampsia. Preliminary results]. ( Beaufils, M; Colau, JC; Donsimoni, R; Uzan, S, 1984) |
| "Low birth weight due to intrauterine growth restriction is associated with various diseases in adulthood, such as hypertension, cardiovascular disease, insulin resistance and end-stage renal disease." | 2.43 | Consequences of intrauterine growth restriction for the kidney. ( Delemarre-van de Waal, H; Schreuder, M; van Wijk, A, 2006) |
| "Both astrogliosis and microgliosis were observed in the hippocampus and white matter at postnatal day (PND)7 with IL-1Ra being protective." | 1.62 | Prenatal administration of IL-1Ra attenuate the neurodevelopmental impacts following non-pathogenic inflammation during pregnancy. ( Brien, ME; Girard, S; Hughes, K, 2021) |
| "The precise etiopathogenesis of preeclampsia (PE) still remains enigmatic." | 1.43 | Second trimester amniotic fluid uric acid, potassium, and cysteine to methionine ratio levels as possible signs of early preeclampsia: A case report. ( Athanasiadis, AP; Biliaderis, CG; Fotiou, M; Koulourida, V; Masoura, S; Menexes, G; Michaelidou, AM; Tarlatzis, BC, 2016) |
| "Medical records of patients with preeclampsia and patients with PIH who delivered at term between January 2003 and December 2004 were reviewed." | 1.35 | Retinopathy in preeclampsia: association with birth weight and uric acid level. ( Gupta, A; Kaliaperumal, S; Rao, VA; Setia, S; Suchi, ST, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (18.75) | 18.7374 |
| 1990's | 9 (18.75) | 18.2507 |
| 2000's | 13 (27.08) | 29.6817 |
| 2010's | 11 (22.92) | 24.3611 |
| 2020's | 6 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Nori, W | 1 |
| Ali, AI | 1 |
| Brien, ME | 2 |
| Hughes, K | 1 |
| Girard, S | 3 |
| Bednarek-Jędrzejek, M | 3 |
| Dzidek, S | 3 |
| Tousty, P | 3 |
| Kwiatkowska, E | 3 |
| Cymbaluk-Płoska, A | 3 |
| Góra, T | 3 |
| Czuba, B | 3 |
| Torbé, A | 3 |
| Kwiatkowski, S | 3 |
| Pang, TT | 1 |
| Zhou, ZX | 1 |
| Li, PS | 1 |
| Ma, HT | 1 |
| Shen, XY | 1 |
| Wan, YC | 1 |
| Guo, XL | 1 |
| Liu, ZP | 1 |
| Chen, GD | 1 |
| Baker, BC | 1 |
| Heazell, AEP | 1 |
| Sibley, C | 1 |
| Wright, R | 1 |
| Bischof, H | 1 |
| Beards, F | 1 |
| Guevara, T | 1 |
| Jones, RL | 2 |
| Hu, J | 1 |
| Xu, W | 1 |
| Yang, H | 1 |
| Mu, L | 1 |
| Moreno Santillan, AA | 1 |
| Briones Garduño, JC | 1 |
| Diaz de Leon Ponce, MA | 1 |
| Khaliq, OP | 1 |
| Konoshita, T | 1 |
| Moodley, J | 1 |
| Naicker, T | 1 |
| Le, TM | 1 |
| Nguyen, LH | 1 |
| Phan, NL | 1 |
| Le, DD | 1 |
| Nguyen, HVQ | 1 |
| Truong, VQ | 1 |
| Cao, TN | 1 |
| Sidiropoulou, EJ | 1 |
| Paltoglou, G | 1 |
| Valsamakis, G | 1 |
| Margeli, A | 1 |
| Mantzou, A | 1 |
| Papassotiriou, I | 1 |
| Hassiakos, D | 1 |
| Iacovidou, N | 1 |
| Mastorakos, G | 1 |
| Barneo-Caragol, C | 1 |
| Martínez-Morillo, E | 1 |
| Rodríguez-González, S | 1 |
| Lequerica-Fernández, P | 1 |
| Vega-Naredo, I | 1 |
| Álvarez, FV | 1 |
| Koh, JH | 1 |
| Ko, HS | 1 |
| Kwok, SK | 1 |
| Ju, JH | 1 |
| Park, SH | 1 |
| Asghar, ZA | 1 |
| Thompson, A | 1 |
| Chi, M | 1 |
| Cusumano, A | 1 |
| Scheaffer, S | 1 |
| Al-Hammadi, N | 1 |
| Saben, JL | 1 |
| Moley, KH | 1 |
| Duval, C | 1 |
| Palacios, J | 1 |
| Boufaied, I | 1 |
| Hudon-Thibeault, AA | 1 |
| Nadeau-Vallée, M | 1 |
| Vaillancourt, C | 1 |
| Sibley, CP | 1 |
| Abrahams, VM | 1 |
| Fotiou, M | 1 |
| Michaelidou, AM | 1 |
| Masoura, S | 1 |
| Menexes, G | 1 |
| Koulourida, V | 1 |
| Biliaderis, CG | 1 |
| Tarlatzis, BC | 1 |
| Athanasiadis, AP | 1 |
| Anastasakis, E | 1 |
| Papantoniou, N | 1 |
| Daskalakis, G | 1 |
| Mesogitis, S | 1 |
| Antsaklis, A | 1 |
| Gupta, A | 1 |
| Kaliaperumal, S | 1 |
| Setia, S | 1 |
| Suchi, ST | 1 |
| Rao, VA | 1 |
| Feig, DI | 1 |
| Laughon, SK | 1 |
| Catov, J | 1 |
| Roberts, JM | 1 |
| Anumba, DO | 1 |
| Lincoln, K | 1 |
| Robson, SC | 1 |
| Mattos, SS | 1 |
| Chaves, ME | 1 |
| Costa, SM | 1 |
| Ishigami, AC | 1 |
| Rêgo, SB | 1 |
| Souto Maior, V | 1 |
| Severi, R | 1 |
| de Lima Filho, JL | 1 |
| Williams, KP | 1 |
| Galerneau, F | 1 |
| Stepan, H | 1 |
| Heihoff-Klose, A | 1 |
| Faber, R | 1 |
| Palmer, BF | 1 |
| Karri, K | 1 |
| Mowbray, D | 1 |
| Itoh, Y | 1 |
| Suzuki, Y | 1 |
| Yamamoto, T | 1 |
| Kojima, K | 1 |
| Murakami, I | 1 |
| Suzumori, N | 1 |
| Thangaratinam, S | 1 |
| Ismail, KM | 1 |
| Sharp, S | 1 |
| Coomarasamy, A | 1 |
| Khan, KS | 1 |
| Habek, D | 1 |
| Bobic, MV | 1 |
| Habek, JC | 1 |
| Schreuder, M | 1 |
| Delemarre-van de Waal, H | 1 |
| van Wijk, A | 1 |
| Giapros, V | 1 |
| Papadimitriou, P | 1 |
| Challa, A | 1 |
| Andronikou, S | 1 |
| Varma, TR | 1 |
| Beaufils, M | 4 |
| Uzan, S | 4 |
| Donsimoni, R | 4 |
| Colau, JC | 3 |
| Sagen, N | 1 |
| Haram, K | 1 |
| Nilsen, ST | 1 |
| Whigham, KA | 1 |
| Howie, PW | 1 |
| Shah, MM | 1 |
| Prentice, CR | 1 |
| Sibai, BM | 1 |
| Abdella, TN | 1 |
| Anderson, GD | 1 |
| McCubbin, JH | 1 |
| Brault, D | 1 |
| López, MC | 1 |
| Belizán, JM | 1 |
| Villar, J | 1 |
| Bergel, E | 1 |
| Jauniaux, E | 1 |
| Gulbis, B | 1 |
| Tunkel, S | 1 |
| Ramsay, B | 1 |
| Campbell, S | 1 |
| Meuris, S | 1 |
| Odendaal, HJ | 1 |
| Pienaar, ME | 1 |
| Surányi, A | 1 |
| Pál, A | 1 |
| Streitman, K | 1 |
| Pintér, S | 1 |
| Kovács, L | 1 |
| Vosatka, RJ | 1 |
| Hassoun, PM | 1 |
| Harvey-Wilkes, KB | 1 |
| Bissenden, JG | 1 |
| Scott, PH | 1 |
| Milner, S | 1 |
| Doughty, S | 1 |
| Ratnapala, L | 1 |
| Wharton, BA | 1 |
| Acién, P | 1 |
| Lloret, G | 1 |
| Lloret, M | 1 |
| el-Roeiy, A | 1 |
| Myers, SA | 1 |
| Gleicher, N | 1 |
| Tartagni, M | 1 |
| Loizzi, P | 1 |
| Diaferia, A | 1 |
| Ceci, O | 1 |
| Jacobson, SL | 1 |
| Imhof, R | 1 |
| Manning, N | 1 |
| Mannion, V | 1 |
| Little, D | 1 |
| Rey, E | 1 |
| Redman, C | 1 |
| Uzan, M | 1 |
| Mareck, A | 1 |
| Salat-Baroux, J | 1 |
| Sureau, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women[NCT05622838] | 160 participants (Anticipated) | Observational | 2022-12-31 | Not yet recruiting | |||
| A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174] | 420 participants (Anticipated) | Interventional | 2019-08-02 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for uric acid and Fetal Growth Restriction
| Article | Year |
|---|---|
Uric acid participating in female reproductive disorders: a review.
Topics: Amniotic Fluid; Endometriosis; Female; Fetal Growth Retardation; Gonadal Steroid Hormones; Humans; I | 2021 |
The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia?
Topics: Biomarkers; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Uric Acid | 2018 |
Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.
Topics: Biomarkers; Cesarean Section; Female; Fetal Growth Retardation; HELLP Syndrome; Humans; Hypertension | 2006 |
Consequences of intrauterine growth restriction for the kidney.
Topics: Animals; Apoptosis; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Insulin | 2006 |
4 trials available for uric acid and Fetal Growth Restriction
| Article | Year |
|---|---|
Oncotic therapy in management of preeclampsia.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dextrans; Female; Fetal Blood; Fetal Growth Retardat | 2006 |
[Controlled trial of preventive treatment of preeclampsia. Preliminary results].
Topics: Adult; Aspirin; Blood Volume; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardati | 1984 |
The measurement of diastolic blood pressure during pregnancy: which Korotkoff phase should be used?
Topics: Blood Pressure; Blood Pressure Determination; Female; Fetal Growth Retardation; Humans; Hypertension | 1994 |
Prospective controlled study of early antiplatelet therapy in prevention of preeclampsia.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardation; Humans; Pa | 1986 |
40 other studies available for uric acid and Fetal Growth Restriction
| Article | Year |
|---|---|
Maternal alpha-1-antitrypsin as a noval marker for growth restriction in pre-eclampsia.
Topics: Female; Fetal Growth Retardation; Fetal Weight; Fetus; Humans; Pre-Eclampsia; Pregnancy; Uric Acid | 2021 |
Prenatal administration of IL-1Ra attenuate the neurodevelopmental impacts following non-pathogenic inflammation during pregnancy.
Topics: Animals; Animals, Newborn; Brain; Disease Models, Animal; Female; Fetal Development; Fetal Growth Re | 2021 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers-The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)-An Exploratory Study.
Topics: Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Place | 2022 |
Associations of early pregnancy serum uric acid levels with risk of gestational diabetes and birth outcomes: a retrospective cohort study.
Topics: Diabetes, Gestational; Female; Fetal Growth Retardation; Fetal Macrosomia; Humans; Hyperuricemia; In | 2023 |
Hypoxia and oxidative stress induce sterile placental inflammation in vitro.
Topics: Adult; Cell Hypoxia; Cell-Free Nucleic Acids; Cytokines; Female; Fetal Growth Retardation; HMGB1 Pro | 2021 |
Uric Acid in Pregnancy: New Concepts.
Topics: Apgar Score; Biomarkers; Case-Control Studies; Female; Fetal Development; Fetal Growth Retardation; | 2018 |
Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia.
Topics: Adult; Apgar Score; Cross-Sectional Studies; Eclampsia; Female; Fetal Growth Retardation; Humans; In | 2019 |
Biochemistry, hormones and adipocytokines in prepubertal children born with IUGR evoke metabolic, hepatic and renal derangements.
Topics: Adiponectin; Alanine Transaminase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Analysis of Varian | 2018 |
Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia.
Topics: Adult; Age of Onset; Biomarkers; Creatinine; Diagnosis, Differential; Female; Fetal Growth Retardati | 2019 |
Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Apgar Score; Female; Fetal Growth Retardation; Follow-Up Studies; Human | 2015 |
Maternal fructose drives placental uric acid production leading to adverse fetal outcomes.
Topics: Allopurinol; AMP Deaminase; Animals; Disease Models, Animal; Female; Fetal Growth Retardation; Fruct | 2016 |
Uric Acid Crystals Induce Placental Inflammation and Alter Trophoblast Function via an IL-1-Dependent Pathway: Implications for Fetal Growth Restriction.
Topics: Animals; Chorioamnionitis; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fetal | 2017 |
Second trimester amniotic fluid uric acid, potassium, and cysteine to methionine ratio levels as possible signs of early preeclampsia: A case report.
Topics: Adult; Amniocentesis; Amniotic Fluid; Biomarkers; Cysteine; Female; Fetal Growth Retardation; Humans | 2016 |
Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Fetal Growth Retardation; Follow-Up Studies; Gestat | 2008 |
Retinopathy in preeclampsia: association with birth weight and uric acid level.
Topics: Adolescent; Adult; Birth Weight; Blood Pressure; Female; Fetal Growth Retardation; Humans; Infant, N | 2008 |
Prenatal programming: maybe not so hopeless after all?
Topics: Child, Preschool; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Low Birth Weight; | 2009 |
Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women.
Topics: Adult; Birth Weight; Blood Glucose; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnanc | 2009 |
Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension.
Topics: Adolescent; Adult; Blood Pressure; Female; Fetal Growth Retardation; Gestational Age; Humans; Hypert | 2010 |
Which growth criteria better predict fetal programming?
Topics: Adult; Female; Fetal Blood; Fetal Development; Fetal Growth Retardation; Humans; Infant, Newborn; In | 2013 |
The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies.
Topics: Biomarkers; Case-Control Studies; Female; Fetal Growth Retardation; HELLP Syndrome; Humans; Infant, | 2002 |
Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion.
Topics: Adult; Antioxidants; Female; Fetal Growth Retardation; Humans; Oxidative Stress; Placental Circulati | 2004 |
Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Endothelium, Vascular; Fetal Growth Retar | 2004 |
Abdominal pain and hyperuricaemia in pregnancy.
Topics: Abdominal Pain; Adult; Apgar Score; Birth Weight; Female; Fetal Growth Retardation; Fluid Therapy; F | 2005 |
Increase in serum concentrations of inhibin in early onset pre-eclampsia with intrauterine growth restriction.
Topics: Adult; Case-Control Studies; Female; Fetal Growth Retardation; Humans; Inhibins; Placental Circulati | 2006 |
The effect of intrauterine growth retardation on renal function in the first two months of life.
Topics: Aminoglycosides; Calcium; Creatinine; Electrolytes; Fetal Growth Retardation; Gestational Age; Human | 2007 |
Serum uric acid levels as an index of fetal prognosis in pregnancies complicated by pre-existing hypertension and pre-eclampsia of pregnancy.
Topics: Birth Weight; Estrogens; Female; Fetal Distress; Fetal Growth Retardation; Humans; Hypertension; Inf | 1982 |
Serum urate as a predictor of fetal outcome in severe pre-eclampsia.
Topics: Adolescent; Adult; Erythrocyte Volume; Female; Fetal Death; Fetal Distress; Fetal Growth Retardation | 1984 |
Factor VIII related antigen/coagulant activity ratio as a predictor of fetal growth retardation: a comparison with hormone and uric acid measurements.
Topics: Antigens; Blood Coagulation; Creatinine; Estriol; Estrogens; Factor VIII; Female; Fetal Growth Retar | 1980 |
Plasma volume determination in pregnancies complicated by chronic hypertension and intrauterine fetal demise.
Topics: Adult; Blood Pressure; Body Surface Area; Creatinine; Female; Fetal Death; Fetal Growth Retardation; | 1982 |
Metabolism of uric acid in normal and pathologic pregnancy.
Topics: Female; Fetal Growth Retardation; Humans; Hypertension; Pregnancy; Pregnancy Complications; Pregnanc | 1981 |
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Female; Fetal Growth Retardation; Gestational Age; Human | 1996 |
Are high uric acid levels in patients with early pre-eclampsia an indication for delivery?
Topics: Adult; Antihypertensive Agents; Creatinine; Female; Fetal Growth Retardation; Gestational Age; Human | 1997 |
Fetal renal hyperechogenicity in pathological pregnancies.
Topics: Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Kidney; Pre-Eclampsia; P | 1997 |
Dietary L-arginine prevents fetal growth restriction in rats.
Topics: Animals; Arginine; Atmospheric Pressure; Diet; Embryonic and Fetal Development; Endothelins; Female; | 1998 |
The biochemistry of amniotic fluid with poor fetal growth.
Topics: Amniotic Fluid; Asia; Birth Weight; Diet; England; Female; Fetal Growth Retardation; Humans; Hydroxy | 1979 |
Perinatal morbidity and mortality in pregnancy hypertensive disorders: prognostic value of the clinical and laboratory findings.
Topics: Adult; Albuminuria; Estriol; Female; Fetal Growth Retardation; Gestational Age; Hematocrit; Humans; | 1990 |
The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy.
Topics: Adult; Autoantibodies; Blood Pressure; Creatinine; DNA; Female; Fetal Growth Retardation; Gestationa | 1991 |
Relationship between some maternal haemato-clinical parameters and low neonatal weight. Preliminary study.
Topics: Birth Weight; Blood Pressure; Body Weight; Female; Fetal Growth Retardation; Hematocrit; Hemoglobins | 1990 |
The value of Doppler assessment of the uteroplacental circulation in predicting preeclampsia or intrauterine growth retardation.
Topics: Blood Flow Velocity; Female; Fetal Growth Retardation; Humans; Placenta; Pre-Eclampsia; Predictive V | 1990 |
[Measurement of maternal plasma volume during pregnancy].
Topics: Adult; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Plasma | 1988 |